The covid vaccine is based on the Zika vaccine...That Obama funded https://www.genengnews.com/topics/omics/moderna-wins-up-to-125m-from-barda-toward-zika-mrna-vaccine/ Moderna Therapeutics said today it will receive up to $125 million from the Biomedical Advanced Research and Development Authority (BARDA) toward developing a Zika virus vaccine. The award is the second potentially nine-figure BARDA contract awarded in less than a week toward Zika vaccine development. On Thursday, Takeda Pharmaceutical announced an award of up to $312 million toward its own inactivated, adjuvanted, whole Zika virus vaccine. Moderna said its BARDA award will accelerate development of a Zika messenger RNA (mRNA) vaccine. The award will consist of an initial $8 million to support a Phase I clinical study, toxicology studies, vaccine formulation, and manufacturing—as well as options for additional funding of up to $117 million to support Phase II and Phase III studies, as well as large-scale manufacturing. “We plan to initiate a Phase I study within the next several months,” Moderna CEO Stéphane Bancel said in a statement. “We believe our mRNA vaccine technology offers potential advantages in efficacy, speed of development, and production scalability and reliability, which may position Moderna as a leader in preparing for and responding to infectious disease threats, such as Zika.” Moderna said it has already carried out preclinical work for the Zika mRNA vaccine, funded through a grant from the Defense Advanced Research Projects Agency (DARPA). Efforts to develop Moderna’s Zika mRNA vaccine are being led by the company’s infectious disease-focused venture, Valera. Moderna’s vaccines are designed to deliver mRNA to the body’s cells, which respond by producing antigenic proteins that are identified and remembered by the immune system. When a person is exposed to the pathogen in the future, Moderna reasons, his or her body will mount an immune response, including production of antibodies that can help to destroy the pathogen. To date, Moderna said, it has launched two Phase I studies assessing its mRNA vaccine in undisclosed infectious diseases in the U.S. and Europe, with approximately 250 volunteers dosed to date. The company expects to publish clinical data on its first Phase I study next year. Separately today, Moderna said it received $474 million in equity financing from undisclosed “existing institutional investors and world-class strategic pharmaceutical partners as well as participation of new institutional investors from the United States, Europe and Asia.” Combined with previous funding, Moderna said it now has $1.4 billion in cash, plus the potential for $230 million more—consisting of the BARDA award, another up-to-$100 million from the Bill & Melinda Gates Foundation disclosed in January, and funding from DARPA.
Moderna’s partnership with the feds to develop messenger RNA technology, which its coronavirus vaccine is based on, began long before the novel coronavirus flared up. The Pentagon funded the company’s mRNA research in 2013, and the federal government gave it $125 million to develop a mRNA-based Zika vaccine in 2016. Its COVID-related work on January 13 appears to have been completed under an already existing research agreement with the NIH, according to a review by the consumer advocacy group Public Citizen. In short, Trump didn’t swoop in to launch the Moderna-NIH COVID vaccine partnership. Rather, his administration piggybacked on an ongoing collaboration whose initial agreements were signed in—checking the fine print—November 2015. Maybe Ivanka should have added, “Thanks, Obama.” Washington, DC – Today, at a hearing of the House Select Subcommittee on the Coronavirus Crisis, Congressman Bill Foster (D-IL) highlighted the work done and investments made during the Obama administration that are directly responsible for the successes of current vaccines in development. Specifically, Foster pointed to President Obama’s decision to invest in mRNA vaccine research, which is one platform being used to develop potential vaccines in record time. Foster said, “Heeding the advice of his scientific panel, in 2013 the Obama Administration invested $25 million through DARPA for research into the mRNA platform for pandemic response. This was followed by a $125 million investment by BARDA in 2015, so that by the end of the Obama administration, mRNA vaccines and therapeutics were being tested in both animals and humans. “The reasons the Obama administration prioritized mRNA vaccines and therapeutics were speed of manufacture, and potency. Without those kinds of investments, “Project Warp Speed” and current efforts to produce an effective COVID-19 vaccine as quickly as possible would not be finding success.”
Did Trump guarantee to buy vaccines even if they were not approved Did Trump push away red tape to manufacturer before approval
A vaccine was created in Germany funded by the German government first,and Europeans were being vaccinated before Americans.That means even if there was no Trump there would be a vaccine.There probably wouldn't be a vaccine yet if not for Obama funding the research in 2013 and 2015 though.
So that was the suggested approach of... wait for it... the Gates Foundation. Bill Gates’ foundation suggested not only funding multiple vaccine developers but also funding the building of the manufacturing for each knowing that some would fail. It was a good plan, if only the vaccines didn’t have microchips in them.